Search filters

List of works by Joel Pekow

ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer

scientific article published on 3 August 2016

Association Between Higher Predicted Serum Vitamin D Levels and Reduced Incidence of Inflammatory Bowel Diseases

scientific article published on July 26, 2012

Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia

scientific article published on July 16, 2011

Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital

scientific article

EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators

scientific article published on 08 June 2011

Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease

scientific article published on 24 August 2017

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

scientific article published on August 15, 2013

MicroRNAs in inflammatory bowel disease

scientific article published on March 18, 2011

Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab

scientific article

Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis

scientific article published on 08 June 2016

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease

scientific article published on 3 May 2017

The emerging role of miRNAs in inflammatory bowel disease: a review

scientific article published on January 2015

The features of mucosa-associated microbiota in primary sclerosing cholangitis

scientific article published on 9 February 2016

Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

scientific article

miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.

scientific article